| For: | Wang YC, Zhang CG, Wang YW, Guo C, Pan T, Yu PJ, Cai BJ, Ding RH, Qiang JL, Deng CQ, Hu CH, Xu YH. SOX plus sintilimab vs P-SOX vs SOX as neoadjuvant therapy in advanced gastric cancer: Efficacy and safety. World J Gastrointest Oncol 2025; 17(8): 109646 [PMID: 40837776 DOI: 10.4251/wjgo.v17.i8.109646] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i8/109646.htm |
| Number | Citing Articles |
| 1 |
Nabil Ismaili. Shifting paradigm in locally advanced resectable gastric and gastroesophageal junction cancers. World Journal of Gastrointestinal Oncology 2026; 18(2): 113150 doi: 10.4251/wjgo.v18.i2.113150
|
